Aardvark Therapeutics AARD
NASDAQ AARD
$1.37 +0.02 (+1.48%)
At close: Nov 10, 2026 · 4:00 PM EST

Aardvark Therapeutics (AARD) Other Operating Expenses (2024)

Updated

Aardvark Therapeutics (AARD) posted Other Operating Expenses of $117,000 for FY2024.

Analysis

Aardvark Therapeutics (AARD) Other Operating Expenses (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Aardvark Therapeutics 30.58 Mn -43.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 14,000.00
Mar 31, 2024 103,000.00
API Access

Aardvark Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AARD&period=max&api_key=YOUR_API_KEY